CK-MB Assay (CK-MB Assay )
- UID
- IMP/IVD/2023/000207_be688de8e7d4c353540450cb49ae31d3_dfc1c7891886838c6ff6b804e4cad709
- Device class
- Class B
- Brand name
- CLIA
- License holder
- Rapid House
- Approving authority
- CDSCO
- Product information
- CK-MB Assay (CLIA) is for the in vitro quantitative determination of creatine kinase MB (CLIA) in human serum and plasma
CK-MB Assay (CK-MB Assay ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000207_be688de8e7d4c353540450cb49ae31d3_dfc1c7891886838c6ff6b804e4cad709. This device is marketed under the brand name CLIA. The license holder is Rapid House, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.